Healthcare / Medical DistributionSão Paulo
$6.86
-0.19 (-2.70%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $430.3M · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$841M
P/E
8.0x
↓EV/EBITDA
3.9x
↓ROE
8.8%
↑Gross Margin
15.3%
↓Debt/Equity
1.04
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+13.6%
FCF CAGR
+54.9%
FCF margin
3.8%
FCF / Net income
3.62x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.45B · net income $118.9M · FCF $430.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.45B | $11.45B | $10.15B | $8.66B | $7.82B |
| Net Income | $118.9M | $118.9M | $114.6M | $70.4M | $80.9M |
| EBITDA | $518.8M | $518.8M | $446.8M | $353.4M | $331.8M |
| EPS | 0.97 | 0.97 | 0.93 | 0.57 | 0.66 |
| Gross Margin | 15.3% | 15.3% | 15.0% | 14.9% | 14.7% |
| Operating Margin | 3.1% | 3.1% | 3.0% | 2.6% | 2.7% |
| Net Margin | 1.0% | 1.0% | 1.1% | 0.8% | 1.0% |
| Balance Sheet | |||||
| Debt/Equity | 1.04 | 1.04 | 0.96 | 0.92 | 0.86 |
| Current Ratio | 1.33 | 1.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $430.3M | $430.3M | $469.0M | $246.9M | $115.8M |
| Returns | |||||
| ROE | 8.8% | 8.8% | 8.8% | 5.6% | 6.8% |
| Valuation | |||||
| P/E | 7.98 | 7.98 | 6.52 | 9.15 | 5.14 |
| EV/EBITDA | 3.87 | 3.87 | 3.95 | 4.51 | 3.79 |
| P/B | 0.63 | 0.63 | 0.57 | 0.52 | 0.35 |
| Growth & Yield | |||||
| Revenue Growth | 12.8% | 12.8% | 17.2% | 10.8% | — |
| EPS Growth | 3.9% | 3.9% | 62.7% | -13.0% | — |
| Dividend Yield | 13.2% | 13.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-14.4%
EPS terminal req.
$0.61
Spread vs growth
18.2%
5Y implied EPS CAGR
-5.4%
EPS terminal req.
$0.74
Spread vs growth
9.2%
10Y implied EPS CAGR
2.0%
EPS terminal req.
$1.19
Spread vs growth
1.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-7.8%
Start / end P/E
9.3x → 7.1x
EPS bridge
0.93 → 0.97
Residual
-0.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.